STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma

Chidzonga, 2006, Squamous cell carcinoma of the oral cavity, maxillary antrum and lip in a Zimbabwean population: a descriptive epidemiological study, Oral Oncol, 42, 184, 10.1016/j.oraloncology.2005.07.011

Chidzonga, 2006, Oral malignant neoplasia: a survey of 428 cases in two Zimbabwean hospitals, Oral Oncol, 42, 177, 10.1016/j.oraloncology.2005.07.003

Dimery, 1993, Overview of combined modality therapies for head and neck cancer, J Natl Cancer Inst, 85, 95, 10.1093/jnci/85.2.95

Schantz, 2002, Head and neck cancer incidence trends in young Americans, 1973–1997, with a special analysis for tongue cancer, Arch Otolaryngol Head Neck Surg, 128, 268, 10.1001/archotol.128.3.268

Llewellyn, 2003, Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997, Oral Oncol, 39, 106, 10.1016/S1368-8375(02)00026-X

Dudley, 2002, Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes, Science, 298, 850, 10.1126/science.1076514

Négrier, 2002, Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie, Ann Oncol, 13, 1460, 10.1093/annonc/mdf257

Rosenberg, 2001, Progress in human tumour immunology and immunotherapy, Nature, 411, 380, 10.1038/35077246

Boniface, 2007, A role for T cell-derived interleukin 22 in psoriatic skin inflammation, Clin Exp Immunol, 150, 407, 10.1111/j.1365-2249.2007.03511.x

Wolk, 2006, Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells, Cytokine Growth Factor Rev, 17, 367, 10.1016/j.cytogfr.2006.09.001

Trifari, 2009, Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells, Nat Immunol, 10, 864, 10.1038/ni.1770

Wolk, 2004, IL-22 increases the innate immunity of tissues, Immunity, 21, 241, 10.1016/j.immuni.2004.07.007

Lejeune, 2002, Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10, J Biol Chem, 277, 33676, 10.1074/jbc.M204204200

Radaeva, 2004, Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation, Hepatology, 39, 1332, 10.1002/hep.20184

Ziesché, 2007, The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells, J Biol Chem, 282, 16006, 10.1074/jbc.M611040200

Zhang, 2008, Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts, Clin Cancer Res, 14, 6432, 10.1158/1078-0432.CCR-07-4401

Weber, 2006, IL-22-mediated tumor growth reduction correlates with inhibition of ERK1/2 and AKT phosphorylation and induction of cell cycle arrest in the G2-M phase, J Immunol, 177, 8266, 10.4049/jimmunol.177.11.8266

Nagakawa, 2004, Expression of interleukin-22 in murine carcinoma cells did not influence tumour growth in vivo but did improve survival of the inoculated hosts, Scand J Immunol, 60, 449, 10.1111/j.0300-9475.2004.01504.x

Matsuo, 1994, New human oral squamous carcinoma cell line and its tumorigenic subline producing granulocyte colony-stimulating factor, Jpn J Cancer Res, 85, 1257, 10.1111/j.1349-7006.1994.tb02938.x

Takahashi, 1989, Establishment and characterization of a cell line (SAS) from poorly differentiated human squamous cell carcinoma of the tongue, J Jpn Stomatol Soc, 38, 20

Morifuji, 2000, Differential expression of cytokeratin after orthotopic implantation of newly established human tongue cancer cell lines of defined metastatic ability, Am J Pathol, 156, 1317, 10.1016/S0002-9440(10)65002-X

Yuan, 2006, Statistical analysis of real-time PCR data, BMC Bioinformatics, 7, 85, 10.1186/1471-2105-7-85

Wolk, 2006, IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis, Eur J Immunol, 36, 1309, 10.1002/eji.200535503

Boniface, 2005, IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes, J Immunol, 174, 3695, 10.4049/jimmunol.174.6.3695

Lee, 2006, Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas, Mol Cancer Ther, 5, 8, 10.1158/1535-7163.MCT-05-0069

Wei, 2001, The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI3-K/Akt pathway, Oncogene, 20, 5799, 10.1038/sj.onc.1204733

Zhong, 1999, Direct comparison of GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards for quantifying RNA levels under hypoxia, Biochem Biophys Res Commun, 259, 523, 10.1006/bbrc.1999.0815

Hagihara, 2004, IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system, Biochem Biophys Res Commun, 314, 363, 10.1016/j.bbrc.2003.12.096

Vandesompele, 2002, Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol, 3, 0034, 10.1186/gb-2002-3-7-research0034

Kato, 1977, Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma, Cancer, 40, 1621, 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I

Duk, 1990, Cancer of the uterine cervix: sensitivity and specificity of serum squamous cell carcinoma antigen determinations, Gynecol Oncol, 39, 186, 10.1016/0090-8258(90)90430-S

Duk, 1996, Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma, J Clin Oncol, 14, 111, 10.1200/JCO.1996.14.1.111

Molina, 2003, Tumor markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis. Comparison with the main clinical and pathological prognostic factors, Tumour Biol, 24, 209, 10.1159/000074432

Zhong, 1994, Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6, Science, 264, 95, 10.1126/science.8140422

Schuringa, 2001, Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation, FEBS Lett, 495, 71, 10.1016/S0014-5793(01)02354-7

Weber, 2005, SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition, Oncogene, 24, 6699, 10.1038/sj.onc.1208818

Hernández-Quintero, 2006, Interleukin-6 promotes human epidermal keratinocyte proliferation and keratin cytoskeleton reorganization in culture, Cell Tissue Res, 325, 77, 10.1007/s00441-006-0173-9

Eichner, 1984, Classification of epidermal keratins according to their immunoreactivity, isoelectric point, and mode of expression, J Cell Biol, 98, 1388, 10.1083/jcb.98.4.1388

Fuchs, 1990, Epidermal differentiation: the bare essentials, J Cell Biol, 111, 2807, 10.1083/jcb.111.6.2807

Porter, 1996, Gene targeting at the mouse cytokeratin 10 locus: severe skin fragility and changes of cytokeratin expression in the epidermis, J Cell Biol, 132, 925, 10.1083/jcb.132.5.925

Fuchs, 1994, Intermediate filaments: structure, dynamics, function, and disease, Annu Rev Biochem, 63, 345, 10.1146/annurev.bi.63.070194.002021

Fuchs, 1995, Keratins and the skin, Annu Rev Cell Dev Biol, 11, 123, 10.1146/annurev.cb.11.110195.001011

Suminami, 2001, Suppression of a squamous cell carcinoma (SCC)-related serpin, SCC antigen, inhibits tumor growth with increased intratumor infiltration of natural killer cells, Cancer Res, 61, 1776

Hashimoto, 2005, Effect of SCCA1 and SCCA2 on the suppression of TNF-alpha-induced cell death by impeding the release of mitochondrial cytochrome c in an oral squamous cell carcinoma cell line, Tumour Biol, 26, 165, 10.1159/000086949

Ahmed, 2009, Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells, Biochem Biophys Res Commun, 378, 821, 10.1016/j.bbrc.2008.11.147